Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 5, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Tercica Raises $21.5M, Gains Rights To IGF-1 From Genentech

May 24, 2002

By Aaron Lorenzo

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...